We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shortwave Life Sciences Plc | AQSE:PSY | Aquis Stock Exchange | Ordinary Share | GB00BL6CJQ54 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.30 | 0.10 | 0.40 | 0.30 | 0.25 | 0.30 | 0.00 | 15:29:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2024 16:42 | Current share price 18th. January 2024: 2.95p 361,203,467 shares in issue Market capitalisation: £10.6555M. "Psych Capital identifies, funds and builds UK and European companies in psychedelic healthcare. Our mission is to support a new wave of innovators who challenge the status-quo and revolutionise how society deals with mental health conditions." "Psych Capital Plc is an incubation and investment firm focused on the emerging psychedelic science and healthcare industry. Part of its portfolio is its wholly-owned “PSYCH”: a data, insights and networking platform for the psychedelic science and healthcare industry. It has quickly become the industry’s leading resource – powered by trustworthy data, independent analysis and engaging events that attract a highly influential audience of policy makers, scientists and investors." 09 Jun 22, 07:00 Psych Capital PLC - Admission to trading on AQSE "Admission to trading on AQSE Psych Capital Plc, the psychedelic healthcare incubation and investment company, that operates the leading industry data, insights, and networking platform, PSYCH, with over 20,000+ subscribers and over 3,000 delegates to previous events, is pleased to announce that admission of its shares to trading on the Aquis Stock Exchange Growth Market ("AQSE Growth Market") will commence at 8.00a.m. today under the TIDM "PSY" and the ISIN number GB00BL6CJQ54. The Company's Admission Document is available at the Company's website: hxxps://psych.capita Key Highlights · The Company currently has exposure to key segments of the medical psychedelic sector through strategic acquisitions and investments, including: · Clinical research in connection with the development of psychedelic medicines used to treat addiction; · Data collection in relation to developments in the psychedelic sector (including, the legal framework, commerce and science); and · Media and communications platform for the medical psychedelic industry · The Company intends to identify, fund and support the building of future companies across three core pillars: therapeutic treatments, drug development, and data/artificial intelligence · The Company will leverage its portfolio of brands, and network of experts, to identify early-stage opportunities in the medical psychedelic industry · The Psych Platform is a global B2B resource for networking, intelligence, and insights, servicing the industry through publications, newsletters and engaging events · PSYCH Symposium events generate strong revenue through sponsorship and ticket sales. Compelling Investment Proposition Psych Capital is a publicly listed incubation and investment firm that deploys early stage capital whilst building or supporting new companies in Europe's psychedelic science and healthcare industry. PSYCH is a data and intelligence platform for the psychedelic science and healthcare industry. It has quickly become the industry's leading resource - powered by trustworthy data, independent analysis and engaging events that attract a highly influential audience of policy makers, scientists and investors. Market Opportunity The nascent psychedelics' space is quickly being harnessed by a growing base of institutional investors seeking to establish and scale businesses in a landscape showing scientific and commercial promise. · Psych's offering aims to capitalise on the following market dynamics: · Numerous companies are currently creating training plans for psychedelic therapists, including the MIND Foundation and COMPASS Pathway; · The United Nations (UN) Convention on Psychotropic Substances framework for the international control of psychotropic substances lists: Psilocybin, MDMA, DMT and LSD as Schedule I substances, the category indicating the least harm with medical application; · Ketamine is on the WHO list of essential medicines; · Psilocybin therapy is expected to be a key driver in societal education and a contributor to wider reforms across America; · MDMA-assisted therapy can take a strong market share from 2024; · Capital invested in psychedelic companies is over US$2 billion; and · The current value of medical businesses surpasses US$10 billion. For example, ATAI Life Sciences' initial public offering (IPO) last year made it the most valuable publicly-traded business in the sector, currently valued at US$595 million. Placing The Company has raised gross proceeds of £810k from the issue and allotment of 16,200,000 Placing Shares. The Company intends to apply the net proceeds raised from the fundraising activities to support its general working capital requirements and to develop its existing business, whilst certain funds may be applied to enable the Company to make further acquisitions. Total voting rights Following Admission, the total number of Ordinary Shares in issue will be 290,033,335 each with equal voting rights. The Company does not hold any rights in treasury. The total voting rights figure can be used by Shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change of their interest in, the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority. William Potts, Chief Investment Officer and Co-Founder of Psych Capital, commented: "We're the first pure play Psychedelic company to list on a UK stock market at an inflection point for the industry as global interest moves towards the UK due to the leading science and companies here. We believe our IPO is a milestone for the whole psychedelic industry in the UK. "With an escalating global mental health crisis, there's a significant opportunity for innovation to cater to unmet needs and improve patient outcomes worldwide. Encouraged by breakthrough trials and science of psychedelic-assisted therapy, our mission is to support a new wave of innovators who are well positioned to challenge the status-quo and revolutionise how society deals with mental health conditions." ..." N.B. The £810K. (gross) was raised at an issue price of 5p/share. | hedgehog 100 | |
23/11/2007 11:14 | What are the main motivating factors of investors? fear or greed? in fact no... - the answer is sociability. fear and greed are around, but sociability is a constant driving characteristic of humanity. We want to be where our friends are or at least where others are who we can relate to on a daily basis. and it leads many to buy-sell what is popular, so that may rub off on us. It makes you feel good too. Predators will also feed of the sociable of course. That is balanced by positive posters who are more altruistic, helping witha dvice and maybe better skills than others. Sociability creates the feel good factor. It is also a key to reassurance. fear and greed, are real all right but are fleeting emotions. In fact once fear has been taken on board for some hours, the body and mind reject it and force alternative strategies . For example, selling shares even at a loss to get rid of the fear sensation. Sociability drives us to favourite threads and to favourite shares. Sociability kicks in from the moment we get up. Fear and greed, are not in the same league. simple as that.. H. | hectorp | |
28/10/2005 07:48 | mahamamsa Thanks for your input. We have looked at the other aspects you mention. I suppose I was looking for someone to say that the hearing panel was not qualified to put their interpretation on the incident and that it would not be normal behaviour to show aggression towards someone with your back towards them thus putting their decision in doubt. Thanks for your time. | kanebill | |
27/10/2005 23:34 | kanebill, I suggest that this is a matter of Employment Law, a subject which I know very little about. And it would depend, I think, on your friend's circumstances, and the level of protection she has in her job. For example, has she been working in the job for long enough to give her protection against unfair dismissal? In terms of a court/tribunal, it's possible that a psychologist could be an expert witness - clearly screaming at computers is something that many of us do. Is your friend a member of a Trade Union? They would provide advice. What about the Citizen's Advice Bureau? | mahamamsa | |
27/10/2005 22:28 | get your mate to tell her to drop the complaint or she will DIE in an accident...that usually works | joe moon | |
27/10/2005 22:11 | Just to keep this live a little longer. | kanebill | |
27/10/2005 21:20 | The real question, from the behavioural point of view, is "Is it normal behaviour to display aggression with your back to someone who is next to you?" | kanebill | |
27/10/2005 20:03 | OK I'll present the facts as known to me. My friend was sitting at a computer trying to use an unfamiliar application/hardware setup and was having problems. She admits to swearing and making hand gestures but maintains that it was only a normal reaction to express her frustration. No threats or actions were directed towards the other person. Th other person later made claims that the agressive gestures and inappropriate language were directed towards her. There was no other person present. The hearing panel decided against my friend purely on the fact that she admitted making the gestures and the use of inappropriate language for which she has apologised. I am trying to find out if their 'non expert' decision could be challenged. | kanebill | |
27/10/2005 19:50 | In this case, given you've given no details, you don't need an expert's opinion. The answer is simple - YES, gestures that aren't seen CAN be 'legitimately construed as aggressive towards an individual'. What if a person is blind? Does this mean that someone's gestures or language can't be construed as being aggressive, just because they can't be seen? BTW I'm not a Chartered Psychologist, but I do have two degrees in psychology. Not that that's got any bearing on the validity of my answer, because as I've said, given the information you've divulged, the answer is clearly yes. Though if you are looking for an expert, maybe it's a lawyer that's needed, not a psychologist? | mahamamsa | |
27/10/2005 19:43 | I can make my own judgements - I need an expert opinion. Someones job depends on it. | kanebill | |
27/10/2005 19:33 | kanebill, Put it another way: 'If you're on the telephone... can your gestures or language be legitimately construed as aggressive towards an individual?' Even more so if you're in close physical proximity. Of course it depends what has been said, and what the context was. If the person said 'I'm going to to smash your head in', that would be definitely aggressive. If the person said 'I'm going to the sports shop to buy a cricket bat' that would depend on the context. | mahamamsa | |
27/10/2005 19:16 | Last resort. Advice required urgently as stated above. Is anybody out there qualified (or know of anyone) to help provide information to assist a friend in a disciplinary hearing. It is a one line question with a conditional follow-up. If you have your back to someone, with no eye contact, can your gestures or language be legitimately construed as aggressive towards an individual? If yes; Could someone without expert opinion be considered an able person to make that judgement?. | kanebill | |
14/6/2002 17:12 | I'm not convinced about rule 3. Provided you haven't deviated from your system and provided that your system has a positive expectation then it would be unwise to ignore any trading signals generated by it. If you do, you are extending the amount of time it will take to recoup losses. | goatbreath | |
10/6/2002 16:06 | Read something recently - a piece of text that someone claimed to read before each day's trading. Can't remember exactly how it went, but it contained something along the lines of: - ... remember you are biologically and socially programmed to fail at this game ... These two may relate more to my own trading difficulties: - you are most vulnerable after you have had a series of winning trades - stay away from the 1 minute chart | nc | |
20/4/2002 13:18 | Losos In the order form we have, there is an option to deliver to an address other than the registered c.c. address (usually home), but people may not appreciate why office delivery can be better - avoids couriers turning up at private addresses and leaving a card. Good idea of yours to remind them in the auto-email acknowledgement. | bookshop | |
20/4/2002 09:34 | hterag1 The courier/Royal Mail issue is a vexed one. The problem with Royal Mail is that they keep losing things. It's much worse now than it was a year ago. With low value items, we can take it on the chin, but once we get above £50 or the weight of the parcel is above 2kg, it is a lot cheaper and safer to send by courier. As you've pointed out, couriers have their own problems, because if you're not home when they call, you get one of their wretched cards. I think what we'll do is put something in our auto acknowledgment email which is sent out to customers saying "You package is going to be sent by courier. They need a signature. Is anyone going to be at home tomorrow. If not, please email us before 3pm today." That way, at least you've got a chance of avoiding the problem. Anyway, I'm sorry it was such a hassle for you. If you ping me an email (pjenks@global-inves Philip | bookshop | |
18/4/2002 21:45 | You might be interested in the 150 sets of rules in 'The Book of Investing Rules' (2001) Philip | bookshop | |
12/4/2002 11:55 | moonblue - I agree | march | |
12/4/2002 11:08 | Trade to win. | pmeas | |
11/4/2002 20:10 | moonblue why don't you add rule 11) If you cannot beat them join them :) | paulismyname |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions